Financial News
Articles published by Moderna, Inc.
![](https://mms.businesswire.com/media/20210813005239/en/839474/5/KO_LOGO.jpg)
Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals
August 13, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210812005877/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210809005485/en/839474/5/KO_LOGO.jpg)
Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine
August 09, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210806005268/en/839474/5/KO_LOGO.jpg)
Moderna Named Fast Company’s 2021 Best Workplace for Innovators
August 06, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210805005476/en/839474/5/KO_LOGO.jpg)
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
August 05, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210803005702/en/839474/5/KO_LOGO.jpg)
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345)
August 03, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210802005403/en/839474/5/KO_LOGO.jpg)
Moderna Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA Therapeutic
August 02, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210723005309/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210722005905/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210722005629/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210720005641/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210715005124/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210712005515/en/839474/5/KO_LOGO.jpg)
Moderna Announces Supply Agreement with Argentina for 20 Million Doses of its COVID-19 Vaccine
July 12, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210707005535/en/839474/5/KO_LOGO.jpg)
Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine
July 07, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210701005580/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210629005764/en/839474/5/KO_LOGO.jpg)
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India
June 29, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210629005708/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210628005423/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210622005731/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210618005273/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210616005529/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210615005801/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210614005414/en/839474/5/KO_LOGO.jpg)
Dr. Paul Burton to Join Moderna as Chief Medical Officer
June 14, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210614005371/en/839474/5/KO_LOGO.jpg)
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
June 14, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210611005274/en/839474/5/KO_LOGO.jpg)
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
June 11, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210610005256/en/839474/5/KO_LOGO.jpg)
Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States
June 10, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210607005393/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210607005409/en/839474/5/KO_LOGO.jpg)
Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents
June 07, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
![](https://mms.businesswire.com/media/20210607005399/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20210603005629/en/839474/5/KO_LOGO.jpg)
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
June 03, 2021
From Moderna, Inc.
Via Business Wire
Tickers
MRNA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.